Research graph
References from Resorufin-based ligand-functionalized nanogels for discoidin domain receptor inhibition and controlled drug delivery in ovarian cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Epidemiology and risk factors for ovarian cancer
2023 · External reference
The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer
10.1002/hsr2.936 · 2022 · External reference
Cancer statistics, 2020
2020 · External reference
Deep learning framework for the prediction and diagnosis of ovarian cancer in Pre- and post-menopausal women
10.3390/diagnostics13101703 · 2023 · External reference
Clinical symptoms of patients with early-stage and advanced-stage ovarian cancer
10.33371/ijoc.v18i3.1134 · 2024 · External reference
Tumor microenvironment complexity: emerging roles in cancer therapy
10.1158/0008-5472.can-12-0122 · 2012 · External reference
Research trends and hotspots in the tumor microenvironment of ovarian cancer: a bibliometrics and visualization study from 2005 to 2024
2025 · External reference
Tumor-associated macrophages and platelets in tumor microenvironment and its potential therapeutic role in ovarian cancer
10.1007/s12094-025-03987-x · 2025 · External reference
Front-line therapy of advanced epithelial ovarian cancer: Standard treatment
10.1093/annonc/mdx450 · 2017 · External reference
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer
2022 · External reference
Nanomedicine disrupts stromal barriers to augment drug penetration for improved cancer therapy
10.1002/cjoc.202300642 · 2024 · External reference
Drug delivery systems for overcoming physical barriers in cancer therapy
10.1021/acs.molpharmaceut.5c00474 · 2025 · External reference
Nanotechnology in cancer drug delivery and selective targeting
10.1155/2014/939378 · 2014 · External reference
Beyond matrix stiffness: targeting force-induced cancer drug resistance
10.1016/j.trecan.2023.07.006 · 2023 · External reference
Integrin signaling in cancer cell survival and chemoresistance
10.1155/2012/283181 · 2012 · External reference
The development of avastin
10.1007/978-3-540-33177-3_35 · 2008 · External reference
Advances in targeted nano-delivery of Bevacizumab using nanoparticles: current insights, innovations, and future perspectives
2024 · External reference
Mechanisms of chemotherapy resistance in ovarian cancer
2022 · External reference
Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance
10.1038/s41568-024-00723-5 · 2024 · External reference
Biocompatible hydrogel Co-Delivering salvigenin and iridium (III) complex overcomes cancer stemness and cisplatin resistance in esophageal squamous cell carcinoma
2026 · External reference
Cisplatin-loaded nanoformulations for cancer therapy: a comprehensive review
2022 · External reference
Modulation of electrostatic interactions to improve controlled drug delivery from nanogels
10.1016/j.msec.2016.11.081 · 2017 · External reference
Design and development of polymeric micelles with cleavable links for intracellular drug delivery
10.1016/j.progpolymsci.2012.07.002 · 2013 · External reference
Synthesis of novel N-Vinylpyrrolidone/Acrylic acid nanoparticles as drug delivery carriers of cisplatin to cancer cells
10.1016/j.colsurfb.2019.110566 · 2020 · External reference
All-in-One multifunctional tri-block glycopolymers for targeted delivery of cisplatin and cancer chemotherapy
2025 · External reference
Smart stimuli-responsive nanogels: a potential tool for targeted drug delivery
10.2174/0113816128353985241231111149 · 2025 · External reference
Nanogels as nanocarriers for drug delivery: a review
10.5599/admet.724 · 2019 · External reference
Effects of primary amine-based coatings on microglia internalization of nanogels
10.1016/j.colsurfb.2019.110574 · 2020 · External reference
Selective modulation of A1 astrocytes by drug-loaded nano-structured gel in spinal cord injury
10.1021/acsnano.9b05579 · 2020 · External reference
Application of nanogels as drug delivery systems in multicellular spheroid tumor model
2022 · External reference
Synthesis and biomedical applications of fluorescent nanogels
10.1039/c6py01021k · 2016 · External reference
A magnetic antibody-conjugated nano-system for selective delivery of Ca(OH)2 and taxotere in ovarian cancer cells
10.1038/s42003-022-03966-w · 2022 · External reference
Folate-decorated nanogels for targeted therapy of ovarian cancer
10.1016/j.biomaterials.2011.04.006 · 2011 · External reference
Inhibition of tumor–microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain
10.1073/pnas.1805020115 · 2018 · External reference
Novel insights into the role of discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention
10.1016/j.matbio.2023.12.003 · 2024 · External reference
Prognostic significance of discoidin domain receptor 2 (DDR2) expression in ovarian cancer
2016 · External reference
Stromal DDR2 promotes ovarian cancer metastasis through regulation of metabolism and secretion of extracellular matrix proteins
10.1158/1541-7786.mcr-23-0347 · 2023 · External reference
Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix Metalloproteinase-2
10.1074/jbc.m107571200 · 2002 · External reference
The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
10.1016/j.bbcan.2023.189052 · 2024 · External reference
Hyaluronic acid-polyethyleneimine nanogels for controlled drug delivery in cancer treatment
10.1021/acsanm.2c00524 · 2022 · External reference
Photodynamic, UV-curable and fibre-forming polyvinyl alcohol derivative with broad processability and staining-free antibacterial capability
10.1016/j.eurpolymj.2025.113794 · 2025 · External reference
Water-nucleobase “Stacking”: H-π and lone Pair-π interactions in the atomic resolution crystal structure of an RNA pseudoknot
10.1021/ja0357801 · 2003 · External reference
Metal-coordinated his-tag functionalization of polymeric nanogels for therapeutic applications
10.1021/acsanm.5c05531 · 2026 · External reference
Acidity generated by the tumor microenvironment drives local invasion
10.1158/0008-5472.can-12-2796 · 2013 · External reference
Acidic extracellular microenvironment and cancer
10.1186/1475-2867-13-89 · 2013 · External reference
The acidic tumor microenvironment: a target for smart cancer nano-theranostics
10.1093/nsr/nwx062 · 2018 · External reference
Cisplatin-protein interactions: unexpected drug binding to N-Terminal amine and lysine side chains
10.1021/acs.inorgchem.6b01234 · 2016 · External reference
Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation
10.1002/jps.21103 · 2008 · External reference
pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect
10.1016/j.ijpharm.2015.10.066 · 2015 · External reference
Amino-aromatic interactions in proteins
10.1016/0014-5793(86)80730-x · 1986 · External reference
Cl–π interactions in protein–ligand complexes
10.1110/ps.033910.107 · 2008 · External reference
Interaction and reactivity of cisplatin physisorbed on graphene oxide nano-prototypes
10.3390/nano10061074 · 2020 · External reference
Responsive hydrogels of carboxymethyl cellulose and polyethyleneimine for efficient removal of ionic dye molecules
10.15376/biores.17.4.5785-5802 · 2022 · External reference
PH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents
10.1002/wnan.1389 · 2016 · External reference
Dual-functionalized mesoporous silica nanoparticles for celecoxib delivery: amine grafting and imidazolyl PEI gatekeepers for enhanced loading and controlled release with reduced toxicity
10.3390/molecules29153546 · 2024 · External reference
Nanotechnology-based cisplatin intracellular delivery to enhance chemo-sensitivity of ovarian cancer
10.2147/ijn.s247114 · 2020 · External reference
Novel Aurora A kinase inhibitor fangchinoline enhances Cisplatin–DNA adducts and cisplatin therapeutic efficacy in OVCAR‐3 ovarian cancer cells‐derived xenograft model
10.3390/ijms23031868 · 2022 · External reference
Nanomedicine disrupts stromal barriers to augment drug penetration for improved cancer therapy
10.1002/cjoc.202300642 · ExternalCitation · doi-reference
The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer
10.1002/hsr2.936 · ExternalCitation · doi-reference
Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation
10.1002/jps.21103 · ExternalCitation · doi-reference
PH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents
10.1002/wnan.1389 · ExternalCitation · doi-reference
The development of avastin
10.1007/978-3-540-33177-3_35 · ExternalCitation · doi-reference
Tumor-associated macrophages and platelets in tumor microenvironment and its potential therapeutic role in ovarian cancer
10.1007/s12094-025-03987-x · ExternalCitation · doi-reference
Amino-aromatic interactions in proteins
10.1016/0014-5793(86)80730-x · ExternalCitation · doi-reference
The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
10.1016/j.bbcan.2023.189052 · ExternalCitation · doi-reference
Folate-decorated nanogels for targeted therapy of ovarian cancer
10.1016/j.biomaterials.2011.04.006 · ExternalCitation · doi-reference
Synthesis of novel N-Vinylpyrrolidone/Acrylic acid nanoparticles as drug delivery carriers of cisplatin to cancer cells
10.1016/j.colsurfb.2019.110566 · ExternalCitation · doi-reference
Effects of primary amine-based coatings on microglia internalization of nanogels
10.1016/j.colsurfb.2019.110574 · ExternalCitation · doi-reference
Photodynamic, UV-curable and fibre-forming polyvinyl alcohol derivative with broad processability and staining-free antibacterial capability
10.1016/j.eurpolymj.2025.113794 · ExternalCitation · doi-reference
pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect
10.1016/j.ijpharm.2015.10.066 · ExternalCitation · doi-reference
Novel insights into the role of discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention
10.1016/j.matbio.2023.12.003 · ExternalCitation · doi-reference
Modulation of electrostatic interactions to improve controlled drug delivery from nanogels
10.1016/j.msec.2016.11.081 · ExternalCitation · doi-reference
Design and development of polymeric micelles with cleavable links for intracellular drug delivery
10.1016/j.progpolymsci.2012.07.002 · ExternalCitation · doi-reference
Beyond matrix stiffness: targeting force-induced cancer drug resistance
10.1016/j.trecan.2023.07.006 · ExternalCitation · doi-reference
Cisplatin-protein interactions: unexpected drug binding to N-Terminal amine and lysine side chains
10.1021/acs.inorgchem.6b01234 · ExternalCitation · doi-reference
Drug delivery systems for overcoming physical barriers in cancer therapy
10.1021/acs.molpharmaceut.5c00474 · ExternalCitation · doi-reference
Hyaluronic acid-polyethyleneimine nanogels for controlled drug delivery in cancer treatment
10.1021/acsanm.2c00524 · ExternalCitation · doi-reference
Metal-coordinated his-tag functionalization of polymeric nanogels for therapeutic applications
10.1021/acsanm.5c05531 · ExternalCitation · doi-reference
Selective modulation of A1 astrocytes by drug-loaded nano-structured gel in spinal cord injury
10.1021/acsnano.9b05579 · ExternalCitation · doi-reference
Water-nucleobase “Stacking”: H-π and lone Pair-π interactions in the atomic resolution crystal structure of an RNA pseudoknot
10.1021/ja0357801 · ExternalCitation · doi-reference
Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance
10.1038/s41568-024-00723-5 · ExternalCitation · doi-reference
A magnetic antibody-conjugated nano-system for selective delivery of Ca(OH)2 and taxotere in ovarian cancer cells
10.1038/s42003-022-03966-w · ExternalCitation · doi-reference
Synthesis and biomedical applications of fluorescent nanogels
10.1039/c6py01021k · ExternalCitation · doi-reference
Inhibition of tumor–microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain
10.1073/pnas.1805020115 · ExternalCitation · doi-reference
Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix Metalloproteinase-2
10.1074/jbc.m107571200 · ExternalCitation · doi-reference
Front-line therapy of advanced epithelial ovarian cancer: Standard treatment
10.1093/annonc/mdx450 · ExternalCitation · doi-reference
The acidic tumor microenvironment: a target for smart cancer nano-theranostics
10.1093/nsr/nwx062 · ExternalCitation · doi-reference
Cl–π interactions in protein–ligand complexes
10.1110/ps.033910.107 · ExternalCitation · doi-reference
Integrin signaling in cancer cell survival and chemoresistance
10.1155/2012/283181 · ExternalCitation · doi-reference
Nanotechnology in cancer drug delivery and selective targeting
10.1155/2014/939378 · ExternalCitation · doi-reference
Tumor microenvironment complexity: emerging roles in cancer therapy
10.1158/0008-5472.can-12-0122 · ExternalCitation · doi-reference
Acidity generated by the tumor microenvironment drives local invasion
10.1158/0008-5472.can-12-2796 · ExternalCitation · doi-reference
Stromal DDR2 promotes ovarian cancer metastasis through regulation of metabolism and secretion of extracellular matrix proteins
10.1158/1541-7786.mcr-23-0347 · ExternalCitation · doi-reference
Acidic extracellular microenvironment and cancer
10.1186/1475-2867-13-89 · ExternalCitation · doi-reference
Responsive hydrogels of carboxymethyl cellulose and polyethyleneimine for efficient removal of ionic dye molecules
10.15376/biores.17.4.5785-5802 · ExternalCitation · doi-reference
Nanotechnology-based cisplatin intracellular delivery to enhance chemo-sensitivity of ovarian cancer
10.2147/ijn.s247114 · ExternalCitation · doi-reference
Smart stimuli-responsive nanogels: a potential tool for targeted drug delivery
10.2174/0113816128353985241231111149 · ExternalCitation · doi-reference
Clinical symptoms of patients with early-stage and advanced-stage ovarian cancer
10.33371/ijoc.v18i3.1134 · ExternalCitation · doi-reference
Deep learning framework for the prediction and diagnosis of ovarian cancer in Pre- and post-menopausal women
10.3390/diagnostics13101703 · ExternalCitation · doi-reference
Novel Aurora A kinase inhibitor fangchinoline enhances Cisplatin–DNA adducts and cisplatin therapeutic efficacy in OVCAR‐3 ovarian cancer cells‐derived xenograft model
10.3390/ijms23031868 · ExternalCitation · doi-reference
Dual-functionalized mesoporous silica nanoparticles for celecoxib delivery: amine grafting and imidazolyl PEI gatekeepers for enhanced loading and controlled release with reduced toxicity
10.3390/molecules29153546 · ExternalCitation · doi-reference
Interaction and reactivity of cisplatin physisorbed on graphene oxide nano-prototypes
10.3390/nano10061074 · ExternalCitation · doi-reference
Nanogels as nanocarriers for drug delivery: a review
10.5599/admet.724 · ExternalCitation · doi-reference
